GlassScriptPhysician profile
Fadi Aqeel
NPI 1053990549
$1,160.12
in general payments reported to CMS, 2019-2025
12 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $450 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Education: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.13 |
| Education | $350.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $397.19 | 2024-2025 | Variax, Alphavent |
| Amgen INC. | $157.44 | 2024-2025 | Evenity, Prolia, Prolia |
| Ossur Americas, INC. | $140.94 | 2025 | Unloader One X |
| Smith+Nephew, INC. | $103.91 | 2024-2025 | Grafix Pl, Ascension, Katalyst Bipolar Radial Head System |
| Bioventus LLC | $87.13 | 2025 | Exogen Ultrasound Bone Healing System, Xcell, Durolane |
| Biotissue Holdings INC. | $77.27 | 2025 | |
| Baxter Healthcare | $60.56 | 2025 | Perclot |
| Ossdsign USA Incorporated | $44.91 | 2025 | Ossdsign Catalyst |
| Acera Surgical, INC. | $25.43 | 2025 | Restrata Wound Matrix |
| Si-Bone, INC. | $24.07 | 2024 | |
| Depuy Synthes Sales INC. | $20.81 | 2025 | Monovisc |
| Solventum Corporation | $20.46 | 2025 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Aqeel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.